Sio Capital Management, LLC Protagonist Therapeutics, Inc Transaction History

Sio Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$14.05 - $23.44 $2.98 Million - $4.97 Million	211,917 Added 85.41%	460,044 $10.5 Million
Q3 2023 Nov 14, 2023	BUY	$16.68 - $23.66 $4.14 Million - $5.87 Million	248,127 New	248,127 $4.14 Million
Q4 2022 Feb 13, 2023	BUY	$7.36 - $11.17 $3.2 Million - $4.85 Million	434,635 New	434,635 $4.74 Million
Q4 2021 Feb 14, 2022	SELL	$17.63 - $37.1 $1.59 Million - $3.34 Million	-90,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $1.17 Million - $4.47 Million	90,000 New	90,000 $1.6 Million

248

56.7M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.93B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.